| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $415,062,663 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R61NS149366 | Biomarker Study in Amyotrophic Lateral Sclerosis (ALS) for Early Detection of Misfolded TDP-43 through Nano-QuIC Assays | 000 | 1 | NIH | 9/9/2026 | $1,782,882 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01GM170988 | SoS:BIO: The Shape of Suffering: Topological Tools for Aligning Biomedical Research with Clinical Need and Biological Opportunity | 000 | 1 | NIH | 9/10/2026 | $248,529 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31CA294586 | Routes of tumor-specific CD4 T cell elimination of pancreatic cancer | 001 | 1 | NIH | 9/8/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31CA294586 | Routes of tumor-specific CD4 T cell elimination of pancreatic cancer | 000 | 1 | NIH | 9/8/2026 | $50,114 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 University Ave SE Ste 100 | Minneapolis | MN | 55414-3074 | HENNEPIN | USA | T0856420 | Scholarships for Disadvantaged Students | 00 | 1 | HRSA | 9/23/2026 | $637,635 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K23HL188477 | Developing and Piloting P3: A Patient-Centered Communication Curriculum for Hypertension Care | 000 | 1 | NIH | 9/4/2026 | $179,928 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R13AR088468 | Infusing the Best Evidence into Orthopedic Clinical Decisions and Interventions | 000 | 1 | NIH | 9/7/2026 | $30,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01NS135615 | Cognitive Impairment and Dementia, Vascular Brain Injury, and Atrial Myopathy: Implications for Prevention of Alzheimer's Disease-Related Dementias | 000 | 2 | NIH | 9/3/2026 | $1,035,475 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 University Ave SE Ste 100 | Minneapolis | MN | 55414-3074 | HENNEPIN | USA | T0856427 | Scholarships for Disadvantaged Students | 00 | 1 | HRSA | 9/23/2026 | $650,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R56DE035844 | Inducible T cell Co-Stimulator (ICOS)-Fc Effects in Periodontitis and Periodontal Healing | 000 | 1 | NIH | 7/9/2026 | $609,498 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL179616 | Rapid Cardiac Magnetic Resonance Imaging for Heart Failure | 000 | 1 | NIH | 7/10/2026 | $763,046 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI197980 | Human retrovirus assembly interplay with the actin cortex | 000 | 1 | NIH | 4/21/2026 | $48,621 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U01FD008646 | Advancing Antimicrobial Use Measurement in U.S. Companion Animal Practice | 001 | 2 | FDA | 9/24/2026 | $199,983 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI196684 | Mechanisms and dynamics of genome plasticity in Candida species | 000 | 1 | NIH | 7/10/2026 | $713,383 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM162637 | Engineering Immunocompetent Systems for Modeling, Modulating, and Treating Inflammatory Diseases | 000 | 1 | NIH | 3/20/2026 | $398,144 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DA065635 | Regulation of nucleus accumbens microcircuitry by exogenous opioid exposure | 000 | 1 | NIH | 4/28/2026 | $673,724 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30AI197932 | Development and Implementation of a Cost-Effective Diagnostic Algorithm to Reduce AIDS-Related Deaths among Hospitalized People with Advanced HIV Disease | 000 | 1 | NIH | 5/6/2026 | $55,114 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161283 | TERPENE: Titer Enhancement via Refactored Precursor pathways for Natural Produce Discovery | 000 | 1 | NIH | 5/7/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI194928 | Engineering Adeno-associated virus vectors for the in vivo generation of CAR T cells targeting HIV B cell reservoirs | 001 | 1 | NIH | 5/12/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI194928 | Engineering Adeno-associated virus vectors for the in vivo generation of CAR T cells targeting HIV B cell reservoirs | 000 | 1 | NIH | 5/12/2026 | $35,951 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI189558 | Defining the Mechanism of Intoxication of the Clostridioides difficile Transferase | 000 | 1 | NIH | 2/19/2026 | $529,512 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U34DK141987 | Cardiovascular and Renal Protection with SGLT2 Inhibition in Kidney Transplant Recipients (RENAISSANCE) | 000 | 2 | NIH | 8/26/2026 | $352,966 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA313195 | Single-Cell Signaling Network Profiling of Pooled CRISPR Screens by Mass Cytometry | 000 | 1 | NIH | 5/7/2026 | $406,325 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | P01AI198498 | Exploiting virus and host diversity to define mechanisms of cross-species infections | 000 | 1 | NIH | 6/30/2026 | $2,000,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AG100759 | Addressing Alzheimer's Disease and Alzheimer's Disease Related Dementias Needs in Indigenous Populations: The Indigenous Behavioral and Cognitive Symptoms (IBACS) Checklists | 000 | 1 | NIH | 8/24/2026 | $4,010,962 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 002 | 1 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 001 | 1 | NIH | 3/23/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 000 | 1 | NIH | 3/23/2026 | $47,251 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA314114 | Investigating the Role of AR Extrachromosomal DNA (ecDNA) in Bipolar Androgen Therapy for Advanced Prostate Cancer | 001 | 1 | NIH | 5/19/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA314114 | Investigating the Role of AR Extrachromosomal DNA (ecDNA) in Bipolar Androgen Therapy for Advanced Prostate Cancer | 000 | 1 | NIH | 5/19/2026 | $44,819 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA299669 | Evaluating the impact of nicotine pouch characteristics in the context of a combustible cigarette standard on overall tobacco product use | 000 | 1 | NIH | 5/22/2026 | $621,549 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21DA063305 | Neuropharmacology of Xylazine and Fentanyl Interactions | 000 | 1 | NIH | 5/22/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 University Ave SE Ste 100 | Minneapolis | MN | 55414-3074 | HENNEPIN | USA | T42OH008434 | OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42) | 00 | 21 | CDC | 8/6/2026 | $1,510,241 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161202 | Dynamics of Motile Flagella in Fluid Media | 000 | 1 | NIH | 3/19/2026 | $373,737 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DK148878 | Uromodulin polymerization and peptides as novel targets in kidney stone pathogenesis | 000 | 1 | NIH | 8/28/2026 | $821,457 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DA066533 | Investigating metformin and cocaine interactions in the brain at the level of pharmacokinetics, physiology, and proteomics | 000 | 1 | NIH | 8/28/2026 | $530,369 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K23DK146162 | Technology-Enhanced Adherence to Medication intervention for youth with Type 2 Diabetes (TEAM-T2D) | 000 | 1 | NIH | 3/19/2026 | $177,877 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 University Ave SE Ste 100 | Minneapolis | MN | 55414-3074 | HENNEPIN | USA | 90SIMS0025 | Minnesota Regional Spinal Cord Injury Model System | 00 | 1 | ACL | 9/29/2026 | $559,998 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL186278 | Mechanisms mediating the exaggerated exercise pressor reflex in a murine model of hindlimb ischemia | 000 | 1 | NIH | 9/2/2026 | $765,131 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21LM014912 | Statistical inference for the efficacy and sustainability of interventions in clinical trials with high-dimensional endpoints | 000 | 1 | NIH | 9/19/2026 | $177,858 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U01AI198071 | Strategy Trial of Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis | 001 | 1 | NIH | 9/14/2026 | $314,988 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U01AI198071 | Strategy Trial of Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis | 000 | 1 | NIH | 9/2/2026 | $331,353 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01MH139659 | Progression of Neurometabolic Dysfunction and Mechanisms of Cognitive Training in Mid- to Late-Life Schizophrenia | 000 | 1 | NIH | 9/2/2026 | $719,832 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31HD121262 | Development of an Inclusive and Accessible Grammatical Language Assessment | 000 | 1 | NIH | 9/11/2026 | $50,114 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL180774 | Evolving extracellular matrices evoke signaling pathways that govern cardiomyocyte maturation | 000 | 1 | NIH | 7/3/2026 | $543,957 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD117850 | Thyroid Hormone as a Key Regulator of Neurodevelopment during Early Life Iron Deficiency | 000 | 2 | NIH | 6/15/2026 | $659,035 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21AI190751 | Development of broadly protective Lassa vaccines using the Pichinde virus vector | 000 | 1 | NIH | 4/9/2026 | $192,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AR085049 | The Role of Dynamic Joint Stability in Generalized Joint Hypermobility: AComprehensive Analysis of Biomechanical Contributions to Chronic Pain | 000 | 1 | NIH | 8/31/2026 | $642,674 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K99MH146385 | Mapping neuroendocrine risk for depression across adolescence | 000 | 1 | NIH | 9/1/2026 | $118,589 |
|
